CAS: 706-03-6; 3-(Benzylamino)Propanenitrile

上下游产品

CAS号107-13-1 丙烯腈 | CAS号100-46-9 苄胺 | CAS号25630-14-2 3-(benzylidenea... | CAS号151-18-8 3-氨基丙腈 | CAS号100-52-7 苯甲醛 | CAS号2510-33-0 3-benzyl-1,3-ox... | CAS号775-16-6 1-苄基-3-吡咯酮 | CAS号2547-66-2 1,3,5-三苄基六氢-S-三嗪 | CAS号372-09-8 氰基乙酸 | CAS号221141-87-3 56 反式-(1-苄基-4-苯... | CAS号588-46-5 N-乙酰苄胺 | CAS号25772-94-5 3-(n-苄基-n 甲基氨基)丙酸乙酯 | CAS号25630-14-2 3-(benzylidenea... | CAS号103-83-3 N,N-二甲基苄胺 | CAS号13910-48-0 N-苄基-1,3-丙二胺 | CAS号1208-75-9 1-苄基六氢氮杂卓-4-酮 | CAS号14321-27-8 N-乙基苄胺 | CAS号149692-49-9 3-[苄基(甲基)氨基]丙酸 | CAS号717-73-7 Urea,N-(2-cyano...

1-苄基-3-吡咯烷酮置于ammonium Hydroxide,Dipotassium Peroxodisulfate,Copper(II) Nitrate体系中,用 乙腈 作为反应溶剂,化学反应 15.0H,以10%的收率获得产物3-(苄氨基)丙腈
参考文献:铜氨介导的羰基化合物的氧化
标题:铜氨介导的羰基化合物的氧化
摘要:Nh 4 Oh水溶液中的铜(II),在大多数情况下,与o 2或k 2 S 2 O 8作为辅助氧化剂一起使用时,如果有非常好的碳电絮凝剂,可将酮氧化裂解为腈.对于未活化的酮,观测到的主要反应是酮亚胺的氧化偶联反应,反应生成嗪.
DOI:10.1016/s0040-4039(00)74473-X

专利信息

专利号:US-3862978-A
优先权日:1967-08-24
标 题:Catalytic synthesis of organic halogen compounds from an ethylenically unsaturated compound and a halogenated organic compound
发明人：DECKER DALTON L; MOORE CARL; TOUSIGNANT WILLIAM F
权利人:DOW CHEMICAL CO
摘要:Method for forming a chemical adduct of an ethylenically unsaturated compound with a halogenated organic compound having on a single carbon atom thereof at least two halogen atoms at least one of which is chlorine, bromine or iodine, characterized by employing a catalyst of which the essential members are copper and an amine selected from piperidine, substituted piperidines, cyclohexylamines and secondary amines on which the hydrocarbyl substituents are allyl, benzyl or lower alkyl radicals.

专利号:EP-1836163-B1
优先权日:2004-12-23
标题 :Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
发明人：BREITENSTEIN WERNER; COTTENS SYLVAIN; EHRHARDT CLAUS; JACOBY EDGAR; LORTHIOIS EDWIGE LILIANE JEANNE; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; SELLNER HOLGER; SIMIC OLIVER
权利人:NOVARTIS AG
摘要:Novel 3-mono-, 3,4-di- and 3,4,4,-tri-substituted pyrrolidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on inappropriate activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on inappropriate activity of renin; the use of a compound of that class in the treatment of a disease that depends on inappropriate activity of renin; pharmaceutical formulations comprising a said substituted pyrrolidine compound, and/or a method of treatment comprising administering a said substituted pyrrolidine compound, a method for the manufacture of said substituted pyrrolidine compounds, and novel intermediates and partial steps for their synthesis are described. The substituted pyrrolidine compounds are especially of the formula I wherein the substituents are as described in the specification.

专利号:US-3454657-A
优先权日:1967-08-24
标 题:Catalytic synthesis of organic halogen compounds
发明人：DECKER DALTON L; MOORE CARL; TOUSIGNANT WILLIAM F
权利人:DOW CHEMICAL CO

专利号:JP-2010155798-A
优先权日:2008-12-26
标 题:Synthesis of heteroatom-substituted optically active propanenitriles

专利号:WO-0034226-A1
优先权日:1998-12-10
标 题 :Polyamine transport inhibitors
发明人：POULIN RICHARD; AUDETTE MARIE; CHAREST-GAUDREALT RENE
权利人:UNIV LAVAL; ILEX ONCOLOGY INC; POULIN RICHARD; AUDETTE MARIE; CHAREST GAUDREALT RENE
摘要:The application discloses synthetic derivatives of original polyamines in which a carbon atom to the original polyamine comprises an amide group inhibits the e cellular uptake of a natural polyamine by specifically binding a cellular transporter for a natural polyamine . The synthetic derivatives are used to inhibit the activity of a natural polyamine transporter, in the treatment of disorders involving unrestrained cell proliferation and/or differentiation where control of polyamine transport is required When used in combination with a n inhibitor of polyamine synthesis.

专利号:RU-2151770-C1
优先权日:1994-06-14
标 题 :Derivatives of pyridone carboxylic acid, methods of their synthesis, antitumor agent and pharmaceutical composition